Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$221,947,217
+$37,674,408 QoQ
Shares Held
6,271,467
-5.7% QoQ
Ownership
0.868%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#20
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. ROIV ranks #3 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in ROIV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,947,217 | 6,271,467 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $184,272,809 | 6,652,448 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $139,817,244 | 6,443,191 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $356,989,793 | 23,594,831 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $385,859,769 | 34,237,779 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $464,278,757 | 46,013,752 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $464,278,757 | 46,013,752 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $565,591,826 | 47,809,960 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $624,303,221 | 54,099,066 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $730,977,292 | 69,155,846 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $731,148,848 | 69,368,961 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $779,013,432 | 69,368,961 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $857,712,635 | 73,434,301 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $758,406,096 | 75,238,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $651,201,606 | 88,238,700 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $705,027,213 | 88,238,700 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $284,128,614 | 88,238,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $359,131,509 | 88,238,700 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $435,899,178 | 88,238,700 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $889,446,096 | 88,238,700 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||